Chemoinformaics analysis of 4alpha-Hydroxymethyl-5alpha-cholesta-8,24-dien-3beta-ol
Molecular Weight | 414.674 | nRot | 5 |
Heavy Atom Molecular Weight | 368.306 | nRig | 21 |
Exact Molecular Weight | 414.35 | nRing | 4 |
Solubility: LogS | -5.747 | nHRing | 0 |
Solubility: LogP | 6.329 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 76 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 28 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 79.0365 |
nHD | 2 | BPOL | 46.1475 |
QED | 0.493 |
Synth | 4.668 |
Natural Product Likeliness | 3.402 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.708 |
Pgp-sub | 0.001 |
HIA | 0.013 |
CACO-2 | -4.753 |
MDCK | 0.000012 |
BBB | 0.577 |
PPB | 0.965729 |
VDSS | 2.809 |
FU | 0.0115658 |
CYP1A2-inh | 0.055 |
CYP1A2-sub | 0.482 |
CYP2c19-inh | 0.044 |
CYP2c19-sub | 0.877 |
CYP2c9-inh | 0.133 |
CYP2c9-sub | 0.541 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.831 |
CYP3a4-inh | 0.161 |
CYP3a4-sub | 0.506 |
CL | 19.344 |
T12 | 0.018 |
hERG | 0.073 |
Ames | 0.024 |
ROA | 0.063 |
SkinSen | 0.103 |
Carcinogencity | 0.031 |
EI | 0.009 |
Respiratory | 0.693 |
NR-Aromatase | 0.058 |
Antiviral | No |
Prediction | 0.611991 |